Entity Common Stock, Shares Outstanding of Theravance Biopharma, Inc. from 06 Jun 2014 to 03 Nov 2025

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Theravance Biopharma, Inc. quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 06 Jun 2014 to 03 Nov 2025.
  • Theravance Biopharma, Inc. Entity Common Stock, Shares Outstanding for the quarter ending 03 Nov 2025 was 50,672,431, a 3% increase year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

Theravance Biopharma, Inc. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 50,672,431 +1,498,135 +3% 03 Nov 2025 10-Q 12 Nov 2025 2025 Q3
Q2 2025 50,361,296 +1,439,213 +2.9% 01 Aug 2025 10-Q 13 Aug 2025 2025 Q2
Q1 2025 50,001,332 +1,368,108 +2.8% 02 May 2025 10-Q 12 May 2025 2025 Q1
Q3 2024 49,174,296 -623,570 -1.3% 08 Nov 2024 10-Q 14 Nov 2024 2024 Q3
Q2 2024 48,922,083 -3,891,021 -7.4% 02 Aug 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 48,633,224 -9,164,244 -16% 03 May 2024 10-Q 15 May 2024 2024 Q1
Q3 2023 49,797,866 -17,568,046 -26% 01 Nov 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 52,813,104 -23,614,140 -31% 01 Aug 2023 10-Q 09 Aug 2023 2023 Q2
Q1 2023 57,797,468 -18,317,925 -24% 01 May 2023 10-Q/A 18 May 2023 2023 Q1
Q3 2022 67,365,912 -6,332,476 -8.6% 31 Oct 2022 10-Q 09 Nov 2022 2022 Q3
Q2 2022 76,427,244 +2,957,093 +4% 01 Aug 2022 10-Q 08 Aug 2022 2022 Q2
Q1 2022 76,115,393 +10,836,306 +17% 29 Apr 2022 10-Q 06 May 2022 2022 Q1
Q3 2021 73,698,388 +9,717,071 +15% 29 Oct 2021 10-Q 08 Nov 2021 2021 Q3
Q2 2021 73,470,151 +9,954,741 +16% 30 Jul 2021 10-Q 05 Aug 2021 2021 Q2
Q1 2021 65,279,087 +2,190,956 +3.5% 30 Apr 2021 10-Q 06 May 2021 2021 Q1
Q3 2020 63,981,317 +7,219,010 +13% 30 Oct 2020 10-Q 09 Nov 2020 2020 Q3
Q2 2020 63,515,410 +6,878,372 +12% 31 Jul 2020 10-Q 10 Aug 2020 2020 Q2
Q1 2020 63,088,131 +6,950,956 +12% 30 Apr 2020 10-Q 08 May 2020 2020 Q1
Q3 2019 56,762,307 +1,351,043 +2.4% 25 Oct 2019 10-Q 08 Nov 2019 2019 Q3
Q2 2019 56,637,038 +1,532,911 +2.8% 26 Jul 2019 10-Q 05 Aug 2019 2019 Q2
Q1 2019 56,137,175 +1,283,317 +2.3% 30 Apr 2019 10-Q 10 May 2019 2019 Q1
Q3 2018 55,411,264 +1,307,886 +2.4% 31 Oct 2018 10-Q 08 Nov 2018 2018 Q3
Q2 2018 55,104,127 +1,274,655 +2.4% 31 Jul 2018 10-Q 02 Aug 2018 2018 Q2
Q1 2018 54,853,858 +1,492,684 +2.8% 01 May 2018 10-Q 09 May 2018 2018 Q1
Q4 2017 54,380,851 +1,525,364 +2.9% 31 Jan 2018 10-K 28 Feb 2018 2017 FY
Q3 2017 54,103,378 +2,160,889 +4.2% 01 Nov 2017 10-Q 08 Nov 2017 2017 Q3
Q2 2017 53,829,472 +5,977,624 +12% 01 Aug 2017 10-Q 09 Aug 2017 2017 Q2
Q1 2017 53,361,174 +14,929,531 +39% 01 May 2017 10-Q 10 May 2017 2017 Q1
Q4 2016 52,855,487 31 Jan 2017 10-K 01 Mar 2017 2016 FY
Q3 2016 51,942,489 +14,103,304 +37% 03 Nov 2016 10-Q 09 Nov 2016 2016 Q3
Q2 2016 47,851,848 +13,913,150 +41% 01 Aug 2016 10-Q 09 Aug 2016 2016 Q2
Q1 2016 38,431,643 +4,629,916 +14% 29 Feb 2016 10-K 11 Mar 2016 2015 FY
Q3 2015 37,839,185 +5,610,908 +17% 31 Oct 2015 10-Q 12 Nov 2015 2015 Q3
Q2 2015 33,938,698 +1,678,593 +5.2% 31 Jul 2015 10-Q 13 Aug 2015 2015 Q2
Q1 2015 33,801,727 30 Apr 2015 10-Q 13 May 2015 2015 Q1
Q3 2014 32,228,277 31 Oct 2014 10-Q 12 Nov 2014 2014 Q3
Q2 2014 32,260,105 06 Jun 2014 10-Q 24 Jun 2014 2014 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.